Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autism  

Project description unavailable

2008

Funder Autism Speaks
Fiscal Year Funding $150,000.00
Project Number 3031
Principal Investigator Hendren, Robert
Strategic Plan Question Question 4: Which Treatments And Interventions Will Help? (Interventions)
Strategic Plan Objective Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4.8 Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.
Federal or Private? Private
Institution University of California, Davis
State/Country California
Web Link 1 No URL available.
Web Link 2 No URL available.
Web Link 3 No URL available.
New! History/Related Projects Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autism | $150,000.00 | 2009 | 3031
Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autism | $127,500.00 | 2010 | 3031